Not many African countries have been able to develop a robust system for regulating health research within their respective jurisdictions, particularly in the realm of biobanking and genomics. This is not without reason. Aside from underdevelopment and all that it entails or perhaps in consequence thereof, countries in the region have been unable to make significant strides in medical research. But there are exceptions. Amongst the few seeming success stories is Uganda. Nonetheless, although the country has developed what appears to be a functional framework to govern genomic research and biobanking, the consistency of key provisions with international standards, especially those pertaining to privacy of research participants and confidentiality of their health information, is not at all clear. Yet, making this determination – the main objective of this article – is critical in determining the adequacy of protection available to human research subjects in the country.
See generally, National Human Genome Research Institute, Human Genome Project Produces Many Benefits, November17, 2011, available at <https://www.genome.gov/27549135>(last visited February 16, 2016).
9.
World Medical Association (WMA), Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects, 64th WMA General Assembly, Fortaleza, Brazil, October 2013, 8, available at <http://www.wma.net/en/30publications/10policies/b3/> (last visited February 16, 2016).
M. L.Faye, J. W.Mcarthur, and J. D.Sachs, , “The Challenges Facing Landlocked Developing Countries,”Journal of Human Development5, no. 1 (2004): 31–68.
African Studies Center, University of Pennsylvania, East Africa Living Encyclopedia, Uganda: A Profile, available at <http://www.africa.upenn.edu/NEH/uhome.htm> (last visited February 16, 2016).
Uganda, Ministry of Local Government, List of Current Local Government Districts in Uganda, available at <https://molg.go.ug/local-governments/> (last visited February 16, 2016).
18.
Id.
19.
WHO, World Health Report 2000: Health Systems: Improving Performance (Geneva: WHO, 2000): at 155.
20.
See WHO, supra note 2, at 50.
21.
Id., at 51.
22.
Id.
23.
Id., at 70.
24.
R. M.Kasyaba, “Uganda: Fast-Track National Health Insurance Bill,”The Monitor, Sept. 12, 2015, available at <http://allafrica.com/stories/201509130178.html> (last visited February 16, 2016) [hereinafter cited as Kasyaba].
National Human Genome Research Institute, NIH and Well-come Trust Announce Partnership to Support Population-based Genome Studies in Africa, available at <https://www.genome.gov/27540084> (last visited February 16, 2016).
32.
IBRH3AU, Welcome to IBRH3AU Biorepository, available athttp://www.ibru.mak.ac.ug/>(last visited February 16, 2016) [[hereinafter cited as IBRH3AU Biorepository].
Sections 4 and 5 of the UNCST Act (CAP 209), Laws of Uganda. See also Guidelines, id.
45.
Guidelines, supra note 29, at 4.
46.
Id.
47.
Id.
48.
Section 6(e) of the UNHRO Act, Laws of Uganda. See also Guidelines, supra note 29, at 5.
49.
Guidelines, supra note 29, at 5.
50.
Id., at 5, 9.
51.
Id., at 5–6.
52.
Id., at 6, 9.
53.
Id., at 9.
54.
Id.
55.
Id., at 11.
56.
Id., at 13.
57.
Id.
58.
Id., at 14.
59.
Id., at 16.
60.
Id.
61.
Id.
62.
Id.
63.
Id., at 16–17.
64.
Id., at 18.
65.
Id.
66.
Id., at 18–19.
67.
Id., at 19.
68.
Id., at 14.
69.
Id., at 32.
70.
Id., at 28.
71.
Id. Note that there are other bodies with oversight functions over research in Uganda such as Scientific Committees, Data and Safety Monitoring Boards, Community Advisory Boards and Institutional Biosafety Committees. See id., at 6–8.
Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Biomedical Research Involving Human Subjects, 2002, at 33, Guideline 4 (Commentary), available at <http://www.cioms.ch/publications/layout_guide2002.pdf> (last visited February 16, 2016) [hereinafter cited as CIOMS].
91.
Guidelines, supra note 29, at, 16–18.
92.
See CIOMS, supra note 90, at 33–34, Guideline 4 (Commentary).
93.
Guidelines, supra note 29, at 17.
94.
Guidelines, supra note 29, at 18.
95.
The H3Africa framework posits thumbprinting as an alternative to signature. See H3AfricaWorking Group, supra note 89, at 21.
96.
Guidelines, supra note 29, at 18.
97.
See Uganda Bureau of Statistics, Uganda National Household Survey Findings2009/2010, available at <http://www.ubos.org/UNHS0910/chapter3_literacy.html> (last visited February 16, 2016) (reporting that 31 percent of rural dwellers in Ugandans (10 years and above) are illiterate).
98.
Guidelines, supra note 29, at 16.
99.
See CIOMS, supra note 90, 34, Guideline 4 (Commentary).
100.
J.de Vries, A.Abayomi, and K.Littler, , “Addressing Ethical Issues in H3Africa Research – The Views of Research Ethics Committee Members,”The Hugo Journal9, no. 1 (2015): 1–4.
101.
Guidelines, supra note 29, at 28.
102.
M. A.Igbe and C. A.Adebamowo, “Qualitative Study of Knowledge and Attitudes to Biobanking among Lay Persons in Nigeria,”BMC Medical Ethics, 13, no. 27 (2012), available at <http://www.biomedcentral.com/1472-6939/13/27> (last visited February 16, 2016).
103.
Guidelines, supra note 29, at 32.
104.
Id., at 14.
105.
Id., at 17.
106.
Id., at 28.
107.
Id., at 32.
108.
Id., at 2.
109.
Id., at 6–10.
110.
A.Matimba, M. N.Oluka, B. U.Ebeshi, , “Establishment of a Biobank and Pharmacogenetics Database of African Populations,”European Journal of Human Genetics16 (2008): 781.
111.
See CIOMS, supra note 90, at 77, Guideline 18 (Commentary).
